Home Healthcare Healthcare Services Nucleic Acid Therapeutics CDMO Market

Nucleic Acid Therapeutics CDMO Market Size, Share & Trends Analysis Report By Type (Cell & Gene Therapies, RNA-based Therapies, mRNA Therapies, siRNA Therapies, Others), By Service (Process Development & Optimization Services, Manufacturing Services, Analytical & Quality Control Services, Others), By End Use (Pharmaceutical & Biotechnology Companies, Government & Academic Research Institutes) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: April 30, 2026 | Author: Mitiksha Koul | Format: | Report Code: SR4354DR | Pages: 150
Overview TOC Segmentation Methodology
Download Free Sample

Table Of Content

  1. Executive Summary
  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Nucleic Acid Therapeutics CDMO Market Size Analysis
    1. Introduction
    2. Nucleic Acid Therapeutics CDMO Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Cell & Gene Therapies
      2. RNA-based Therapies
      3. mRNA Therapies
      4. siRNA Therapies
      5. Others
    3. Nucleic Acid Therapeutics CDMO Market Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
      1. Process Development & Optimization Services
      2. Manufacturing Services
      3. Analytical & Quality Control Services
      4. Others
    4. Nucleic Acid Therapeutics CDMO Market Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
      1. Pharmaceutical & Biotechnology Companies
      2. Government & Academic Research Institutes
  7. North America Nucleic Acid Therapeutics CDMO Market Size Analysis
    1. Introduction
    2. Nucleic Acid Therapeutics CDMO Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Cell & Gene Therapies
      2. RNA-based Therapies
      3. mRNA Therapies
      4. siRNA Therapies
      5. Others
    3. Nucleic Acid Therapeutics CDMO Market Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
      1. Process Development & Optimization Services
      2. Manufacturing Services
      3. Analytical & Quality Control Services
      4. Others
    4. Nucleic Acid Therapeutics CDMO Market Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
      1. Pharmaceutical & Biotechnology Companies
      2. Government & Academic Research Institutes
    5. U.S.
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
      3. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Process Development & Optimization Services
        2. Manufacturing Services
        3. Analytical & Quality Control Services
        4. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Government & Academic Research Institutes
    6. Canada
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
      3. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Process Development & Optimization Services
        2. Manufacturing Services
        3. Analytical & Quality Control Services
        4. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Government & Academic Research Institutes
  8. Europe Nucleic Acid Therapeutics CDMO Market Size Analysis
    1. Introduction
    2. Nucleic Acid Therapeutics CDMO Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Cell & Gene Therapies
      2. RNA-based Therapies
      3. mRNA Therapies
      4. siRNA Therapies
      5. Others
    3. Nucleic Acid Therapeutics CDMO Market Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
      1. Process Development & Optimization Services
      2. Manufacturing Services
      3. Analytical & Quality Control Services
      4. Others
    4. Nucleic Acid Therapeutics CDMO Market Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
      1. Pharmaceutical & Biotechnology Companies
      2. Government & Academic Research Institutes
    5. U.K.
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
      3. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Process Development & Optimization Services
        2. Manufacturing Services
        3. Analytical & Quality Control Services
        4. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Government & Academic Research Institutes
    6. Germany
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
      3. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Process Development & Optimization Services
        2. Manufacturing Services
        3. Analytical & Quality Control Services
        4. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Government & Academic Research Institutes
    7. France
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
      3. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Process Development & Optimization Services
        2. Manufacturing Services
        3. Analytical & Quality Control Services
        4. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Government & Academic Research Institutes
    8. Spain
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
      3. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Process Development & Optimization Services
        2. Manufacturing Services
        3. Analytical & Quality Control Services
        4. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Government & Academic Research Institutes
    9. Italy
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
      3. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Process Development & Optimization Services
        2. Manufacturing Services
        3. Analytical & Quality Control Services
        4. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Government & Academic Research Institutes
    10. Russia
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
      3. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Process Development & Optimization Services
        2. Manufacturing Services
        3. Analytical & Quality Control Services
        4. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Government & Academic Research Institutes
    11. Nordic
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
      3. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Process Development & Optimization Services
        2. Manufacturing Services
        3. Analytical & Quality Control Services
        4. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Government & Academic Research Institutes
    12. Benelux
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
      3. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Process Development & Optimization Services
        2. Manufacturing Services
        3. Analytical & Quality Control Services
        4. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Government & Academic Research Institutes
    13. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
      3. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Process Development & Optimization Services
        2. Manufacturing Services
        3. Analytical & Quality Control Services
        4. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Government & Academic Research Institutes
  9. APAC Nucleic Acid Therapeutics CDMO Market Size Analysis
    1. Introduction
    2. Nucleic Acid Therapeutics CDMO Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Cell & Gene Therapies
      2. RNA-based Therapies
      3. mRNA Therapies
      4. siRNA Therapies
      5. Others
    3. Nucleic Acid Therapeutics CDMO Market Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
      1. Process Development & Optimization Services
      2. Manufacturing Services
      3. Analytical & Quality Control Services
      4. Others
    4. Nucleic Acid Therapeutics CDMO Market Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
      1. Pharmaceutical & Biotechnology Companies
      2. Government & Academic Research Institutes
    5. China
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
      3. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Process Development & Optimization Services
        2. Manufacturing Services
        3. Analytical & Quality Control Services
        4. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Government & Academic Research Institutes
    6. Korea
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
      3. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Process Development & Optimization Services
        2. Manufacturing Services
        3. Analytical & Quality Control Services
        4. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Government & Academic Research Institutes
    7. Japan
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
      3. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Process Development & Optimization Services
        2. Manufacturing Services
        3. Analytical & Quality Control Services
        4. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Government & Academic Research Institutes
    8. India
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
      3. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Process Development & Optimization Services
        2. Manufacturing Services
        3. Analytical & Quality Control Services
        4. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Government & Academic Research Institutes
    9. Australia
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
      3. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Process Development & Optimization Services
        2. Manufacturing Services
        3. Analytical & Quality Control Services
        4. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Government & Academic Research Institutes
    10. Taiwan
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
      3. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Process Development & Optimization Services
        2. Manufacturing Services
        3. Analytical & Quality Control Services
        4. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Government & Academic Research Institutes
    11. South East Asia
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
      3. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Process Development & Optimization Services
        2. Manufacturing Services
        3. Analytical & Quality Control Services
        4. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Government & Academic Research Institutes
    12. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
      3. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Process Development & Optimization Services
        2. Manufacturing Services
        3. Analytical & Quality Control Services
        4. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Government & Academic Research Institutes
  10. Middle East and Africa Nucleic Acid Therapeutics CDMO Market Size Analysis
    1. Introduction
    2. Nucleic Acid Therapeutics CDMO Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Cell & Gene Therapies
      2. RNA-based Therapies
      3. mRNA Therapies
      4. siRNA Therapies
      5. Others
    3. Nucleic Acid Therapeutics CDMO Market Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
      1. Process Development & Optimization Services
      2. Manufacturing Services
      3. Analytical & Quality Control Services
      4. Others
    4. Nucleic Acid Therapeutics CDMO Market Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
      1. Pharmaceutical & Biotechnology Companies
      2. Government & Academic Research Institutes
    5. UAE
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
      3. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Process Development & Optimization Services
        2. Manufacturing Services
        3. Analytical & Quality Control Services
        4. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Government & Academic Research Institutes
    6. Turkey
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
      3. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Process Development & Optimization Services
        2. Manufacturing Services
        3. Analytical & Quality Control Services
        4. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Government & Academic Research Institutes
    7. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
      3. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Process Development & Optimization Services
        2. Manufacturing Services
        3. Analytical & Quality Control Services
        4. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Government & Academic Research Institutes
    8. South Africa
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
      3. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Process Development & Optimization Services
        2. Manufacturing Services
        3. Analytical & Quality Control Services
        4. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Government & Academic Research Institutes
    9. Egypt
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
      3. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Process Development & Optimization Services
        2. Manufacturing Services
        3. Analytical & Quality Control Services
        4. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Government & Academic Research Institutes
    10. Nigeria
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
      3. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Process Development & Optimization Services
        2. Manufacturing Services
        3. Analytical & Quality Control Services
        4. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Government & Academic Research Institutes
    11. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
      3. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Process Development & Optimization Services
        2. Manufacturing Services
        3. Analytical & Quality Control Services
        4. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Government & Academic Research Institutes
  11. LATAM Nucleic Acid Therapeutics CDMO Market Size Analysis
    1. Introduction
    2. Nucleic Acid Therapeutics CDMO Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Cell & Gene Therapies
      2. RNA-based Therapies
      3. mRNA Therapies
      4. siRNA Therapies
      5. Others
    3. Nucleic Acid Therapeutics CDMO Market Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
      1. Process Development & Optimization Services
      2. Manufacturing Services
      3. Analytical & Quality Control Services
      4. Others
    4. Nucleic Acid Therapeutics CDMO Market Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
      1. Pharmaceutical & Biotechnology Companies
      2. Government & Academic Research Institutes
    5. Brazil
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
      3. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Process Development & Optimization Services
        2. Manufacturing Services
        3. Analytical & Quality Control Services
        4. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Government & Academic Research Institutes
    6. Mexico
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
      3. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Process Development & Optimization Services
        2. Manufacturing Services
        3. Analytical & Quality Control Services
        4. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Government & Academic Research Institutes
    7. Argentina
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
      3. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Process Development & Optimization Services
        2. Manufacturing Services
        3. Analytical & Quality Control Services
        4. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Government & Academic Research Institutes
    8. Chile
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
      3. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Process Development & Optimization Services
        2. Manufacturing Services
        3. Analytical & Quality Control Services
        4. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Government & Academic Research Institutes
    9. Colombia
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
      3. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Process Development & Optimization Services
        2. Manufacturing Services
        3. Analytical & Quality Control Services
        4. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Government & Academic Research Institutes
    10. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
      3. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Process Development & Optimization Services
        2. Manufacturing Services
        3. Analytical & Quality Control Services
        4. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Government & Academic Research Institutes
  12. Competitive Landscape
    1. Nucleic Acid Therapeutics CDMO Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. Agilent Technologies, Inc.
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Thermo Fisher Scientific Inc.
    3. Danaher
    4. Lonza Group AG
    5. Catalent Inc.
    6. WuXi AppTec Co., Ltd.
    7. Bachem AG
    8. BioSpring GmbH
    9. TriLink BioTechnologies
    10. Eurofins Scientific
    11. Ajinomoto Bio-Pharma Services
    12. AGC Biologics, Inc.
    13. PolyPeptide Group AG
    14. Nitto Denko Avecia Inc.
    15. Kaneka Eurogentec S.A.
    16. LGC Group
    17. KNC Laboratories Co., Ltd.
    18. Merck KGaA
    19. Curia Global Inc.
    20. Asymchem Inc.
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  16. Disclaimer
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.